Evaluate portal pressure noninvasively in patients with hepatitis B virus–related liver disease.

Noninvasive Analysis of Portal Pressure by Contrast-Enhanced Sonography in Patients With Cirrhosis

Chao-Xue Zhang, MM, Jing Hu, MM, Kong-Wang Hu, MM, Chao Zhang, MM, Ling Wang, MM and Jian-Ming Xu, MD
Departments of Ultrasound (C.-X.Z., L.W.), Gastroenterology (J.H., J.-M.X.), and General Surgery (K.-W.H., C.Z.), First Affiliated Hospital, Anhui Medical University, Hefei, China.

Address correspondence to Jian-Ming Xu, MD, Department of Gastroenterology, First Affiliated Hospital, Anhui Medical University, 218 Jixi Rd, 230022 Hefei, Anhui, China. E-mail: xjm1017@yahoo.com.cn


Abstract

Objectives—Free portal pressure measurement is a reliable method for assessment of portal pressure in patients with cirrhosis. Intrahepatic circulatory time analysis of a sonographic contrast agent can assess liver fibrosis and its severity. The purposes of this pilot study were to assess the correlation between the intrahepatic circulatory time and free portal pressure and to assess whether intrahepatic circulatory time analysis can be used to predict portal venous pressure severity.

Methods—The intrahepatic circulatory time and free portal pressure were measured in 31 patients with hepatitis B virus–related liver disease. Pearson correlation analysis was used to assess the correlation between the intrahepatic circulatory time and free portal pressure.

Results—The hepatic vein–hepatic artery interval times were significantly shorter in the portal hypertension group than the non–portal hypertension group (mean ± SD, 8.26 ± 1.94 and 13.83 ± 1.17 seconds, respectively; P < .001). The portal vein–hepatic artery interval times were significantly longer in the portal hypertension group than the nonportal hypertension group (13.13 ± 2.25 and 7.25 ± 1.81 seconds; P < .001). Considering the whole patient population, there were statistically significant correlations between free portal pressure and the hepatic vein–hepatic artery interval time (r = –0.900; P < .001) and portal vein–hepatic artery interval time (r = 0.808; P < .001). In patients with portal hypertension, there was a statistically significant correlation between free portal pressure and the hepatic vein–hepatic artery interval time (r = –0.804; P = .009) and a weak correlation between free portal pressure and the portal vein–hepatic artery interval time (r = 0.506; P = .036).

Conclusions—Intrahepatic circulatory time measurement is correlated with free portal pressure and has the potential capability to evaluate portal pressure noninvasively in patients with hepatitis B virus–related liver disease.

http://www.jultrasoundmed.org/cgi/content/abstract/30/2/205
Key Words: cirrhosis • contrast-enhanced sonography • portal hypertension • portal pressure